细胞治疗：SCG星德汉

公司名称：SCG星德汉

领域：细胞治疗（CAR-T，TCR-T），抗体，疫苗，HBV，肝细胞癌（HCC）和宫颈癌（Cervical Cancer）

公司官网：http://www.scghttp://cell.com

成立年份：2018年

HQ：新加坡

办公地点：

上海浦东半夏路100号

50 Raffle Place，37-00 Singapore Land Tower，Singapore

Am Klopferspitz 19，82152 Planegg，Germany

149 Xuecheng Road，Lushunkou District, Dalian，CHINA

类型：星德汉生物，该公司是新加坡星汉德?物医药有限公司（SCG Cell Therapy Pte. Ltd.，以下简称SCG）旗下控股子公司

核心高管：

Scientific Founder：Ulrike Protzer，教授研究方向是病毒学和免疫学领域，慕尼黑工业大学病毒学研究所、德国环境与健康研究中心病毒研究所所长，其团队曾开发了治疗慢性乙型肝炎及其并发症的新治疗方法，在世界范围内首个实现对乙肝病毒共价闭合环状DNA（cccDNA）的特异性清除。

CEO：Frank Wang，is the Chief Executive Officer and Chairman of the Board of Directors of SCG. Before joining SCG, he co-founded BioSyngen Pte. Ltd. and served as its Chairman and Chief Executive Officer.

Frank has a broad range of experience in strategic planning and international businesses. He was a government official of the People's Republic of China for over 15 years involving in economic and policy reforms. He also chaired the Sino-Singapore government collaboration project with Temasek-affiliated companies. Frank received his B.S. from Harbin Institute of Technology in China and MBA from Roosevelt University in the United States.

CSO：Ke Zhang, PhD，Before joining SCG, Dr. Zhang acted as the principal project leader at Janssen/Johnson & Johnson China R&D and led several antiviral projects against chronic hepatitis B and HBV-related hepatocellular carcinoma. Dr. Zhang earned his Ph.D. in Molecular Medicine at the Faculty of Medicine, Technical University of Munich and received his postdoctoral training at the Institute of Medical Virology, Helmholtz Zentrum München - German Research Center for Environmental Health.

CMO：Cai Jun, MD，Dr. Cai Jun is the Senior Vice President in Clinical Development of SCG.

Dr. Cai has experience in all aspects of clinical development, working in both Clinical Operations, Medical and Quality. She most recently served as Vice President of clinical development at IASO Biotherapeutics leading the development of BCMA CAR-T cell therapy. Previously, she held senior roles including Vice President at MedAlly, Vice President at Sihuan Pharmaceutical, China Site Head and China Country Head of Roche Product Development (Asia Pacific), Head of Monitoring & Site Management and Head of Quality, Risk Management & Training and Clinical Affair Officer at GlaxoSmithKline Singapore and China. Dr Cai obtained an M.D. from Tongji University and practiced in Tongji Medical University Hospital, Wuhan. She also received her M.S. in Physiology at the National University of Singapore.

技术平台：

最新pipeline（2022年）：

其他：

欲了解最新在招职位（Scope，汇报线，老板风格，职位要求，地点等）请私信文章标题